glp-1 receptor agonists dizziness side effect Adverse effects of agonists: Clinical Implications, regulatory perspectives, and future directions ๐ DID YOU KNOW? GLP-1
Description
Back Vinfuture Prize Laureates, 'Professor Joel Francis Habener'
10.1016/j.xphs.2019.04.022 2 BainS
Through these studies, potential new opportunities have risen to utilize GLP-1 receptor agonists to treat nonalcoholic fatty liver disease (NAFLD), Parkinson disease, Alzheimer disease, osteoarthritis, and chemical dependency
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al
243 In the local islet environment, a high concentration of somatostatin creates an inhibitory milieu, further reducing the activity of -cells and the secretion of glucagon
